Clinical Trials Browser

Completed × UNKNOWN × Interventional × Clear all

Stomach Neoplasms

Colorectal Neoplasms

Rectal Neoplasms

Breast Neoplasms

Esophageal Neoplasms

Stomach Neoplasms

Advanced Pancreatic Cancer

Rectal Neoplasms

Biliary Tract Neoplasms

Breast Neoplasms

Carcinoma, Carcinoma, Non-Small-Cell Lung, Thoracic Neoplasms

Breast Neoplasms

Esophageal Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Nasopharyngeal Carcinoma

Head and Neck Neoplasms, Vomiting

Breast Neoplasms, Heart Injuries, Radiation Injuries

Brain Neoplasms

Meningeal Carcinomatosis

Stomach Neoplasms

Solitary Pulmonary Nodule, Lung Neoplasms, Multiple Pulmonary Nodules

Colitis, Ulcerative

Breast Neoplasms

Colorectal Neoplasms

Breast Neoplasms

Cancer Pain, Pain

Colorectal Neoplasms

Esophageal Neoplasms

Adenoma, Polyps

Lymphoma, Extranodal NK-T-Cell

Uterine Cervical Neoplasms

Carcinoma, Hepatocellular, Liver Neoplasms

Brain Neoplasms, Meningeal Carcinomatosis

Esophageal Neoplasms

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Solid Tumors

Breast Neoplasms

Rectal Neoplasms

Esophageal Neoplasms

Rectal Neoplasms

Stomach Neoplasms

Cough, Lung Neoplasms, Sarcoidosis, Tuberculosis, Lung Diseases, Interstitial

Small Cell Lung Carcinoma

Stomach Neoplasms

Nasopharyngeal Neoplasms

Stomach Neoplasms

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Gastrointestinal Neoplasms, Stomach Neoplasms

Carcinoma, Non-Small-Cell Lung

Clinical Trials

MATCH

A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer

Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly

Ara-C

Docetaxel+Carboplatin vs Epirubicin+Cyclophosphamide Followed by Docetaxel as Adjuvant Treatment in Triple-negative Breast Cancer

Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trial

Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma

Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer

Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer

The Efficacy and Safety of Nab-paclitaxel Plus S-1 in First-line Treatment of Advanced Biliary Tract Adenocarcinoma

Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer

Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung Cancer

Anlotinib in Metastatic HER2 Negative Breast Cancer

Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01

NMIBC

The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma

Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC

Prospective Assessment of Radiation-induced Heart Injury in Left-sided Breast Cancer

Tomotherapy as Primary Radiotherapy for Multipule Brain Metastases

Tomotherapy for Leptomeningeal Metastases

A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma

3D Printing for Nodule Localization

Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing Colonoscopy

Hypofractionated Radiation Therapy With Concomitant Boost in Treating Women After Breast Conserving Surgery

Effect of Oral Administration of Methylene Blue MMX Tablets on Double Stranded DNA

A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer

Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer

The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy

Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma

Safety Study of SIC 8000 in Subjects Undergoing Endoscopic Mucosal Resection (EMR) of Colonic Lesions Equal to or Larger Than 2 cm

Radiotherapy Combined With GDP Chemotherapy in Stage I/II Extranodal Natural Killer/T-cell Lymphoma

Comparative Study of Different Neoadjuvant Therapies Before Radical Hysterectomy in Stage Ib2-IIa2 Cervical Cancer

Study of Postoperative 3D-CRT/IMRT in Hepatocellular Carcinoma

SRTRBM

Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma

The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents

A Phase Ib Study to Assess Safety and Efficacy of Oral Icaritin in Advanced Solid Tumors

2-weeks of Adjuvant Radiotherapy in Patients With Breast Cancer

Safety Study of Capecitabine With Radiation in Elderly Rectal Cancer

Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma

Study of Postoperative Concurrent Chemo-radiation With Capecitabine in Elderly Rectal Cancer Patients

Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma

A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy

Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer

The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer

The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer

Endoscopic Screening on Esophageal Cancer

A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer

Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)